Skip to content

DocGo DCGO Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year)

Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) at other companies

CVS Health logo
CVS HealthCVS

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's available-for-sale debt securities - amortized cost (due within one year).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's available-for-sale debt securities - amortized cost (due within one year)?
DocGo (DCGO) reported available-for-sale debt securities - amortized cost (due within one year) of $16.16M in Q1 2026.